Skip to main content

DMK Pharmaceuticals Corp

DMKDelisted Mar 21, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000887247

DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding DMK Pharmaceuticals Corp changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of DMK: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders4847−1
Shares12.7M27.6M+14.8M (+116.4%)
Value$2.16M$3.20M+$1.04M (+48.2%)

New holders (5)

Institutions that held DMK Pharmaceuticals Corp at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to DMK in Q1 2023
InstitutionSharesValue% of portfolio
Armistice Capital, LLC14,500,000$1.68M0.04%
Citadel Advisors LLC327,168$37.9K0.00%
Group One Trading, L.P.5,609$6500.00%
Allworth Financial LP3,530$4100.00%
Cape Investment Advisory, Inc.100$120.00%

Sold out (6)

Institutions that held DMK Pharmaceuticals Corp at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of DMK in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Virtu Financial LLC99,893$17.0K
Jane Street Group, LLC96,824$16.4K
HighTower Advisors, LLC57,350$9.00K
Belvedere Trading LLC1,541$260
EverSource Wealth Advisors, LLC620$105
The PNC Financial Services Group, Inc.200$34